Pharmacodynamic Modeling and Exposure-Response Assessment of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders

By
Justin.choi
-
0
86
A hematopoietic transit model was developed to describe the joint effects of reducing influx from pro-B cells and accelerating CD20+ B cell depletion in the blood by inebilizumab.
[British Journal of Clinical Pharmacology]

Sorry, but the selected Zotpress account can't be found.

Abstract